Kaftrio (elexacaftor/tezacaftor/ivacaftor)
Kaftrio is indicated in a combination regimen with ivacaftor for the treatment of cystic fibrosis (CF) in patients aged 6 years and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Brand Name: | Kaftrio |
Generic Name: | elexacaftor/tezacaftor/ivacaftor |
Strength: | |
Manufacturer: | |
Approved By: | EMA, USFDA |
Source Details: Patient Information
IPN, New Delhi can facilitate patient to import of “Kaftrio (elexacaftor/tezacaftor/ivacaftor)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for Kaftrio (elexacaftor/tezacaftor/ivacaftor) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.